Author: Louis Navellier, Investor Place

It’s more than a great dividend payer– it’s a bona fide biopharmaceutical leader.

I’ve run my Portfolio Grader screens, and these are all A-rated winners that are perfect fits in anyone’s portfolio.

It’s downright cheap and a solid pick for any growth investor.

Financial stocks can offer the best of both words — the potential for growth when the markets get their feet under them, and the dividends to tide you over.